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ABSTRACT 
 
West Nile Virus (WNV) made a dramatic intercontinental jump to North America in 1999. Exact 
reasons for its abrupt appearance in NYC are unknown. WNV is now recognized as the most 
widespread disease of its genre and has rapidly spread across the U.S., involving all but 4 states. 
During the 2002 season more than 4000 illnesses and 274 deaths were attributed to WNV. 
Evidence now exists implicating WNV in lactational, intrauterine and organ recipient transmissions 
as well as the viruses potential to infect the U.S. blood supply. 
 
WNV is permanently established as a significant pathogen in the U.S. prompting research 
exploring new treatments, diagnostic tests and vaccines. Research is ongoing regarding the 
mystery of the virus’s emergence in North America and it’s rapid spread across the continent. 
 
Arizona is one of 4 states without endemic WNV activity, although the virus has been identified in 
the border states of New Mexico and Colorado. A single human case in California has also been 
reported without the expected concomitant bird or mosquito viral activity. In 2002 Maricopa 
County dead bird, sentinel flock, mosquito pool, human and equine surveillance plans have been 
enhanced in anticipation of the emergence of WNV in our region. Continuing to draw from the 
experiences of other jurisdictions, Maricopa County WNV prevention efforts will focus on early 
identification of WNV activity in birds and mosquitoes resulting in utilization of measures to 
reduce mosquito breeding habitats, aggressive public education campaigns and graded 
enhancement of human and equine surveillance.  
 
Although these efforts cannot entirely prevent WNV illness the goal is to thwart the viral 
amplification cycles that result in increased risk to humans and domestic animals. This goal can 
only be reached through comprehensive and adequately funded preparation and the well-
coordinated efforts of all stakeholders in both the public and private sectors.
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I. GENERAL BACKGROUND/HISTORY 
 
West Nile Virus (WNV) is one of the group of arboviruses (arthropod-borne) known to cause 
meningitis and encephalitis in humans, such as Western Equine Encephalitis (WEE) and St. Louis 
Encephalitis (SLE) viruses. Other familiar arboviruses cause Yellow fever, Denge fever and 
LaCrosse encephalitis. 
WNV belongs to the Flaviviridae family, the genus Flavivirus Japanese encephalitis antigenic 
complex.  This includes the Alfuy, Cacipacore, Japanese encephalitis, Koutango, Kunjin, Murray 
Valley encephalitis, St. Louis encephalitis, Rocio, Stratford, Usutu, West Nile, and Yaounde 
viruses (2). 
First isolated from the blood of a woman with a febrile illness in the province of West Nile, 
Uganda in 1937, WNV has been a common cause of both animal and human disease in Africa, 
the Middle East, Europe and western Asia. Small outbreaks have occurred in Israel (1999 and 
2000), Algeria (1994), Romania (1996 and 1997), the Czech Republic (1997), the Democratic 
Republic of the Congo (1998), Russia (1999) and the United States (1999-2002) (1). WNV is now 
recognized as the most widespread virus of its genre in the world. 
 
 
Electron micrograph of WNV in brain tissue of a crow  
Illustration 1 
(http://www.cdc.gov/ncidod/dvbid/westnile/virus.htm) 
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Life Cycle of WNV 
The principal vector for WNV and other arboviruses are bird-feeding mosquitoes. Infected 
mosquitoes carry viral particles in their salivary glands and infect susceptible bird species during 
a blood meal. Although mosquitoes of the genus Culex are the primary vectors in the life cycle, 
WNV has been isolated from over 43 other mosquito species (3, 4). 
 
Wild birds are the key reservoir hosts for WNV, which has been isolated from over 160 avian 
species both wild and domestic. Although most infected birds are asymptomatic, crows and jays 
are more likely to become ill or die, often presenting the first clues to the presence of WNV in 
communities. Birds can remain highly viremic for 4-5 days successfully sustaining and amplifying 
the life cycle of the virus in endemic areas (3, 4). 
Humans, equines and other mammals are considered incidental or “dead end” hosts of WNV; 
these species become infected but do not contribute to the viral life cycle. There is however, a 
theoretical risk of transmission to another hosts by way of vector mosquito bites, albeit not yet 
well documented. WNV has been isolated from a wide variety of domestic, zoo and farm species 
(3, 4). For a list of these species, see appendix A. 
 
              
            Incidental Infections 
 
                  
Life Cycle of WNV  
Illustration 2 
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WNV Arrival in the U.S.  
During the summer of 1999, WNV was identified in North America for the first time in a total of 
four U.S. states.  The outbreak in New York City resulted in 62 human cases and 7 deaths.  
It is still unknown how WNV was introduced to North America. Its appearance in an area of 
frequent travel, international trade and bird migration routes suggests the natural or trade-
related importation of exotic animals and plants from overseas as a probable answer (4).  
Examination of the DNA sequence of the virus isolated from both humans and animals in NYC in 
1999 revealed a near 100% match with virus isolated from Israel in 1998 (6, 7).  
The mechanism of WNV's spread through the U.S presents another challenge for scientists.  The 
virus had spread to 12 states and the District of Columbia by the year 2000.  By 2001 it had been 
isolated in animals or humans in 15 additional states and, by 2003, WNV activity was reported in 
a total of 44 states and the District of Columbia.  In 2002 the virus appeared in Pacific coast 
states before it appeared in Southwestern states (2), (See Table 1 and Map 1).  
 
 
 
 
 
Map 1 
(http://www.cdc.gov/ncidod/dvbid/westnile/surv&control.htm#map1) 
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Year 1999 2000 2001 2002* (as of 
1/20/03) 
Cases 62 21 66 3989 
Fatalities 7 2 9 259 
WNV Annual Case Count 
Table 1 
Several hypotheses have been formulated regarding this rapid transcontinental expansion of 
WNV endemic areas in the U.S.: “over-wintering” of infected mosquitoes, that is, the ability to 
survive adverse climatic conditions and remain viable until the next season; the persistence of 
WNV in chronically infected endemic vertebrate hosts such as birds or frogs; persistence of the 
virus in the hibernating female of the Culex species, thus infecting her progeny transovarially; 
and the reintroduction of the virus seasonally by chronically infected migratory birds from tropical 
or subtropical endemic areas (5).  
Clinical Aspects of WNV  
Most human WNV infections result in mild or even absent symptoms after an incubation period of 
3-15 days. Serosurveys performed in NYC confirmed that approximately 20% of those infected 
developed mild disease and less than 1% suffered from severe disease (1,4).  
 
West Nile Fever 
Well documented for many years in Europe, West Nile Fever is a case of mild WNV disease in 
humans, characterized by a 3-15 day incubation followed by abrupt onset of flu-like symptoms 
such as fever, myalgia, arthralgia, pharyngitis, adenopathy, headache, rash, nausea, vomiting 
and malaise (5). West Nile fever typically resolves spontaneously after only a few days and does 
not appear to cause any long-term health effects. 
 
West Nile Meningitis/Encephalitis                                                          
Severe WNV disease, West Nile meningitis or encephalitis, is characterized by fever, severe 
cephalgia and mental status changes. Unique to WNV meningitis and encephalitis are the 
commonly reported patterns of severe muscle weakness and spastic or flaccid paralysis, which 
are unusual in other viral nervous system infections (6). Although rare, the most serious 
manifestation of WN virus infection is fatal encephalitis.  
 
Historical Data: NYC Experience                                                              
During the WNV outbreak in 1999 in NYC the most common symptoms among hospitalized 
patients were fever (90%), weakness (56%), nausea/vomiting (53/51%), headache (47%) and 
mental status changes (46%) (1). 
Age appeared to be the most important risk factor for severe disease; data revealed that the 
attack rate for severe neurologic disease was 10 times higher for those 50-59 years old and 43 
times higher for those 80 years old and above when compared to persons aged 0-19. The 
median age for hospitalized patients during the outbreak was 71 years (range 5-90) and the 
relative risk for death for patients age 75 and over was 8.5 (1, 4) when compared to the younger 
age group (0-19). 
 
A one-year follow up of hospitalized patients affected in the 1999 outbreak revealed significant 
residual symptomatology: fatigue (67%), memory loss (50%), difficulty ambulating (49%), 
muscle weakness (44%), and depression (38%) were reported (4).  
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2002 WNV Outbreak in the U.S. – New Findings 
The 2002 outbreak in the U.S. is the largest documented WNV epidemic in the world to date. 
Several case reports from 2002 have contributed evidence of previously undocumented or poorly 
understood modes of viral transmission.  The new information has prompted reevaluation of 
practices and procedures at the individual as well as the community level.   
 
WNV transmission from organ transplant  
In August 2002, 4 organs from a single donor in Georgia were linked to 3 cases of encephalitis 
(one fatal) and one case of mild febrile illness in the recipients. Three of the four organ recipients 
tested positive for WNV. It is not known how the donor (who was said to have been healthy 
before a fatal accident) contracted the disease but health officials are investigating the blood 
products he received during trauma resuscitation as a potential source of infection with WNV (8). 
 
WNV transmission from blood transfusion  
The Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), with 
state and local health officials are investigating 33 cases from 17 states of WNV illness associated 
with receiving blood products within 30 days of the onset of symptoms. So far, there is evidence 
indicating WNV infection as a result of the transfusion in six of those cases. In each of the six, 
either the donor or retention segments from the blood transfusion (tubing and needles used 
during the transfusion procedure) tested positive for WNV.  Additionally, in each case the donor 
was reported as having had an illness clinically compatible with WNV (9). The FDA has revised 
blood bank guidelines, adding protections to exclude donors with symptoms compatible with 
WNV infection as well as measures to quarantine blood products already in the system from 
donors who become ill after donation. The FDA and other agencies are evaluating a direct rapid 
screening method for WNV and have proposed allowing the use of such a test under the 
“Investigational New Drug” application process during the summer of 2003. The new method will 
enable blood banks to rapidly screen for WNV just as they routinely check for diseases such as 
HIV, syphilis and hepatitis (10). 
 
WNV transmission from nursing mother to infant 
In September 2002, a 40-year-old Michigan woman delivered a healthy infant but required two 
transfusions after the delivery. The patient was readmitted 12 days later with symptoms of 
meningitis, her CSF was WNV positive; she was treated, recovered and was discharged. The 
nursing infant, who is healthy and reportedly had no mosquito exposure, has tested WNV 
positive. A sample of the breast milk was also positive for WNV and a viral culture is pending. Of 
note, the mother received blood from the same donor who also gave a transfusion of platelets to 
a liver transplant patient who subsequently died of WNV encephalitis. The CDC has not issued 
any change in breast-feeding recommendations as a result of this case (11). 
 
Intrauterine Transmission 
In August 2002, a pregnant New York woman was hospitalized for fever, headache, rash and 
weakness in the legs. In October, she tested WNV positive and went on to deliver an infant of 
38-weeks gestation suffering severe cerebral abnormalities. The infants’ blood and CSF tested 
WNV positive; placental and umbilical tissues also tested WNV positive confirming an apparent 
intrauterine infection. The CDC has stressed that these findings do not prove a causal relationship 
between the WNV infection and the fetal abnormalities, however they acknowledge that 
intrauterine infections associated with Japanese encephalitis and Dengue fever have resulted in 
fetal infections and spontaneous abortions have been documented in the literature. Precautions 
for pregnant women to avoid mosquito exposures have been emphasized. In addition, a 
voluntary registry has been established by the CDC to monitor the birth outcomes of pregnant 
women with WNV illness (12). 
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Laboratory Acquired Infections 
Two laboratory-acquired cases of WNV have been documented this year. Although this is not a 
new experience in WNV research there is concern that as far more laboratories will be 
participating in procedures involving WNV infected tissues such exposures will increase. In one 
case a laboratory employee lacerated his thumb with a scalpel performing a necropsy on a dead 
bird subsequently found to be WNV infected. Four days later he began to exhibit typical 
symptoms from which he recovered without hospitalization. In the other case a research 
laboratory employee suffered a needle stick while harvesting WNV infected mouse brains. Three 
days later he began to have symptoms. Of interests in this case the patient had a history of 
Dengue fever and had received both yellow fever and Japanese encephalitis vaccines. Despite 
the presence of these presumptively protective Flavivirus antibodies he still contracted WNV 
illness although the episode was considered mild and the patient recovered completely (13).  
 
The Subcommittee on Arbovirus Laboratory Safety of the American Committee on Arthropod-
Borne Viruses recommends biosafety level 3 (BSL) containment for handling WNV specimens. 
BSL-2 facilities, by modifying procedures, can also achieve acceptable safety standards in order 
to continue to provide essential clinical services. CDC officials have recommended continued 
training and prompt reporting.  A baseline serum and medical follow-up will be required for all 
potential laboratory exposures. (13) 
 
 
II.  WNV SURVEILLANCE IN MARICOPA COUNTY  
In anticipation of the westward spread of the West Nile Virus in 2002 surveillance efforts to 
detect the illness in Maricopa County have been increased during the peak mosquito season of 
May through November.  
 
In endemic areas veterinary surveillance, particularly in avian species, has proven to be a reliable 
early indicator for WNV activity both temporally and geographically (14). As a result the Arizona 
Department of Health Services’ Vector-borne and Zoonotic Disease Program, the Arizona 
Veterinary Diagnostic Laboratory and Maricopa County public health officials have collaborated to 
enhance dead bird, sentinel chicken flock, mosquito pool and equine testing for WNV. 
 
Mosquito Pools 
The Arizona State Health Laboratory (ASHL) has tested over 750 mosquito pools in 2002 from 
locations throughout the state. While no WNV positives occurred 31 samples tested positive for 
WEE or SLE. 
 
Sentinel Chicken Flocks 
Four chicken flocks have been established and strategically spread across the county. Although 
the virus does not affect chickens their serum will indicate antibodies if bitten by WNV infected 
mosquitoes in the area. Over 1500 chicken blood samples from across the state were tested 
during the surveillance season at the ASHL. None tested positive for WNV although the chicken 
flocks did confirm the presence of WEE and SLE in the county.   
 
Dead Bird Submissions 
Dead birds from a variety of genres have been collected from areas across the state. At the 
beginning of the season information was given to the community regarding the proper 
submission of dead birds and their importance in WNV surveillance. The University of Arizona’s 
Veterinary Diagnostic Laboratory performed approximately 200 dead bird necropsies, none were 
WNV positive.  
 
 
 
 10 
Equine 
Local veterinarians have been alerted to consider WNV in horses presenting with CNS 
abnormalities such as ataxia, weakness of the limbs, recumbency and muscle fasciculation. 
Approximately 50 equine serum samples have been tested state wide; one horse residing in 
Maricopa County at the time of diagnosis tested WNV positive, however investigation revealed 
the virus was contracted in another state. Two other WNV-positive horses were identified in 
Arizona counties (Cochise and Pima); these cases were also determined to have out of state 
transmission. 
 
Human Surveillance 
The epidemiology division has employed a set of criteria to enhance surveillance and assure 
appropriate testing of cases of viral neurologic disease for WNV during the peak mosquito 
season. The criteria were designed to closely reflect the WNV experience of endemic areas of the 
U.S. in terms of demographics and symptomatology. Cases meeting the following criteria were 
investigated and tested for WNV: 
 
ü ALL encephalitis cases 
ü Adults (>35) with aseptic meningitis 
ANY age aseptic meningitis with one or more of the following: 
ü Altered mentation 
ü Seizure 
ü Profound muscle weakness 
ü Flaccid paralysis 
ü Spastic paralysis 
 
Details of the results of human surveillance in Maricopa County can be found in Appendix B. Two 
Maricopa County meningitis/encephalitis patients tested positive for WNV at the ASHL; the results 
were confirmed by CDC laboratories. Two other human cases of WNV illness were reported in 
Arizona (Pima). In all four cases the investigation revealed the virus was contracted out of state. 
 
Appendix C denotes the approximate costs of enhanced surveillance in 2002. 
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III.  PLAN OF ACTION FOR WNV IN MARICOPA COUNTY, 2003: 
        SURVEILLANCE/CONTROL 
Human Surveillance Plan  
Resources 
Maricopa County epidemiology has prepared a proposal for reestablishing enhanced surveillance 
for WNV in spring of 2003. (See Appendix D: Epidemiology/Surveillance Plan for West Nile Virus 
2003, 12/12/02). Additional resources requested for the 2003 season include a nurse investigator 
and 2 administrative assistants. Responsibilities will include community outreach, active 
surveillance at Maricopa County hospitals, operating hotline numbers, collection of laboratory 
samples, home and hospital interviews/visits and phlebotomies. A formal process will be followed 
to track the costs incurred to include salaries, travel and equipment.  
 
Risk Assessment and Staged Response 
     The Level of Risk definitions and expected responses can be found in Table 2. Two stages of 
enhanced human surveillance will be guided by the Level of Risk indicated from results of 
enhanced mosquito and bird surveillance.  
 
 
RISK 
LEVEL 
DEFINITION RESPONSE 
I Mosquito Season–no arbovirus 
detected 
Business as usual: continue 
surveillance & education. 
II Virus Detected- mosquitoes &/or birds •Activate active case surveillance in 
affected areas 
•Step-up prevention education 
•Step-up surveillance - affected & 
adjacent areas 
 
III Equine Cases-but still local/focal WNV 
IV Human Cases and/or Widespread WNV 
•Intensify prevention education efforts 
•Expand active human case 
surveillance 
•Increase MD outreach, add sentinel 
hospitals 
Risk Assessment and Staged Epidemiologic Response 
(Reproduced from Risk Assessment and Staged Response from Arizona Department of Health 
Services’ Vector-borne and Zoonotic Disease Program) 
Table 2 
 
Two Stages of Enhanced Human Surveillance 
-“Enhanced Passive Surveillance” will begin at the start of the mosquito season (Risk Level I 
conditions) and will involve promoting prompt reporting of viral encephalitis and select cases of 
meningitis by healthcare institutions and providers. Routine contact with hospital ICP’s and 
laboratories will continue. Public education regarding mosquito reduction and avoidance will 
begin. 
 
-“Active Surveillance” will begin with the announcement of Risk Level II conditions. Active 
surveillance will involve regular formal contact with healthcare institutions and providers, weekly 
e-mail and fax updates, broadcast fax emergency announcements, and on-site interviews and 
sample procurement as needed. Suspect case investigation criteria will be expanded. Public 
education messages will be enhanced to include WNV specific information, prevention messages 
and to publicized hotline numbers. Hotline phones will be engaged to answer public inquiries and 
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provide provider consultations. All efforts will be staged with careful consideration of risk 
assessment and available resources. 
 
The testing/investigation criteria will be amended as follows to reflect recent experiences in 
endemic areas: 
ü All cases of viral encephalitis 
ü Hospitalized cases of aseptic/viral meningitis and: 
o >Age 30 
o Altered mentation 
o Profound muscle weakness 
o Neuropathic symptoms; 
§ Flaccid paralysis 
§ Spastic paralysis 
§ Guillain-Barre Syndrome 
§ Seizure 
 
The age criteria will be heavily dependent upon testing resources (lab capacity, availability of 
reagents) and risk level assessment and will be reevaluated regularly. Cases with travel/mosquito 
bite history, organ or blood transfusion recipients with compatible symptoms will be evaluated on 
an individual basis. 
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IV.  THE FUTURE  
Vaccine 
Human vaccines for WNV are being developed. Drug maker Acambis and National Institutes of 
Health (NIH) researchers are working with an experimental vaccine for WNV using both an 
experimental dengue virus and the existing Yellow Fever vaccines as the foundation for the new 
drug by substituting WNV specific surface proteins for the existing viral particles. Both vaccines 
have been extensively tested on animals with promising results. The Acambis drug is moving 
forward with Phase I Trials and an investigational new drug (IND) application will be filed with 
the Food and Drug Administration. Clinical trials will likely begin in 2003 (15) 
 
Disease Ecology 
Researchers in the U.S. along with our neighbors in Canada and Mexico are investigating the 
mysterious emergence of WNV in North America and the patterns of the virus’s persistence in the 
continent by trying to gain a more detailed understanding of the avian and mosquito species 
involved in the life cycle and how they are affected by climactic and geographical issues (15).  
 
Treatment and Diagnosis 
NIH funded institutions have screened over 300 antiviral and immunotheraputic drugs for 
treatment of WNV. Of these, 12 have shown in vitro activity against the virus warranting animal 
testing.  
Several small biotechnology companies are attempting to develop new, commercially available 
diagnostic assays for WNV. A new rapid diagnostic test will likely become available in late 2003 
(15). 
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V. CONCLUSIONS 
The year 2002 marked the largest WNV outbreak to date in the world as the virus rapidly spread 
across the U.S. The epidemic has cost hundreds of lives and millions of dollars, impacting those 
directly affected as well as the community at large. The magnitude of the spread of the WNV was 
unexpected and as a result health officials in many jurisdictions have struggled to limit its human 
impact.  
 
Maricopa County has been spared the burden of widespread WNV-illness thus far, however the 
area is home to a viable mosquito population, many species of migratory birds and a large 
human populace with a propensity for outdoor activities making arrival of the virus inevitable and 
advanced preparations invaluable.  
 
Maricopa County has the luxury of applying the lessons learned from WNV endemic regions in the 
past four years and must plan accordingly. If we are to interrupt the amplification cycle of WNV 
before significant human impact it will be important to invest heavily in preventive measures 
such as early public awareness messages regarding mosquito control and dead-bird submissions, 
rapid and accurate bird necropsies and concomitant mosquito pool and sentinel flock testing. 
Once local viral activity has been confirmed preplanned strategies for larvacidal applications, 
equine vaccinations and reemphasizing measures for mosquito avoidance should be immediately 
implemented for the appropriate geographical region.  
 
Prior to the identification of WNV activity in Maricopa County enhanced human surveillance must 
already be in progress with sufficient resources to generate comprehensive case investigations 
and assure assessment and testing of all potential WNV cases in the jurisdiction. 
 
As with most significant public health issues the cooperation of many local, state, and federal 
agencies will be required as well as that of the medical community, and the lay public.  
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APPENDIX A 
SPECIES AFFECTED BY WEST NILE VIRUS 
(Reproduced from the National Wildlife Health Center: 
http://www.nwhc.usgs.gov/research/west_nile/wnvaffected.html) 
 
Birds     
Order Anseriformes 
Family Anatidae 
Wood Duck-Aix sponsa 
Eurasian Wigeonc-Anas penelope 
Mallard-Anas platyrhynchos 
Bronze-winged Duck (Spectacled Duck)c-Anas specularis 
Domestic Gooseac-Anser chinensis 
Canvasback-Aythya valisineria 
Canada Goose-Branta Canadensis 
Barnacle Gooseac-Branta leucopsis 
Emperor Goosec-Chen canagica 
Greater Magellan Goose (Andean Goose)ac-Chloephagapicta leucoptera  
Abyssinian Blue-winged Gooseac-Cyanochen cyanopterus 
Tundra Swanc-Cygnus columbianus 
Trumpeter Swanac-Cygnus Cygnus buccinator 
Mute Swan-Cygnus olor 
Rosybilled Duckac-Netta peposaca 
 
Order Apodiformes 
Family Apodidae 
Chimney Swift-Chaetura pelagica 
Family Trochilidae 
Ruby-throated Hummingbird-Archilochus colubris 
 
Order Caprimulgiformes 
Family Caprimulgidae 
Common Nighthawk-Chordeiles minor 
Order Casuariiformes 
Family Dromaiidae 
Emuc-Dromaius novaehollandiae 
Order Charadriiformes 
Family Charadriidae 
Ruddy Turnstone-Arenaria interpres 
Killdeer-Charadrius vociferus 
Family Laridae 
Herring Gull-Larus argentatus 
Laughing Gull-Larus atricilla 
Ring-billed Gull-Larus delawarensis 
Great Black-backed Gull-Larus marinus 
Black Skimmer-Rhynchops niger 
Grey Gullac-Larus modestus 
Order Ciconiformes 
Family Ardeidae 
Yellow-crowned Night-heronc-Nyctanassa violacea 
Black-crowned Night-heronc-Nycticorax nycticorax 
Great Blue Heron-Ardea herodias 
Green Heron-Butorides virescens 
Least Bittern-Ixobrychus exilis 
Family Cathartidae 
Turkey Vulture-Cathartes aura 
Black Vulture-Coragyps atratus 
King Vultureac-Sarcoramphus papa 
Family Ciconiidae 
Saddle-billed Storkac-Ephippiorhynchos senegalensis 
 
 
Marabou Storkac-Leptopilos crumeniferus 
Lesser Adjutant Storkac-Leptoptilos javanicus 
Family Laridae 
Inca Ternac-Larosterna inca 
Family Phoenicopteridae 
Chilean Flamingoc-Phoenicopterus chilensis 
Family Threskiornithidae 
Scarlet Ibisc-Eudocimus ruber 
Waldrappac-Geronticus eremita 
Order Columbiformes  
Family Columbidae 
White-crowned Pigeon-Columba leucocephala 
Rock Dove (Feral Pigeon)-Columba livia 
Mauritius Pink Pigeonac-Columba mayeri 
Common Ground-Dove-Columbina passerina 
Eurasian Collared-Dove-Streptopelia decaocto 
White-winged Dove-Zenaida asiatica 
Mourning Dove-Zenaida macroura 
Luzon Pigeon (Bleeding Heart Pigeon)ac-Gallicolumba luzonica 
Order Coraciiformes 
Family Alcedinidae 
Belted Kingfisher-Ceryle alcyon 
Order Cuculiformes 
Family Cuculidae 
Yellow-billed Cuckoo-Coccyzus americanus 
Order Falconiformes 
Family Accipitridae 
Cooper's Hawk-Accipiter cooperii 
Northern Goshawk-Accipiter gentilis 
Sharp-shinned Hawk-Accipiter striatus 
Golden Eagle-Aquila chrysaetos 
Red-tailed Hawk-Buteo jamaicensis 
Rough-legged Hawkc-Buteo lagopus 
Red-shouldered Hawk-Buteo lineatus 
Broad-winged Hawk-Buteo platypterus 
Swainson's Hawk-Buteo swainsoni 
Swallow-tailed Kite-Elanoides forficatus 
Bald Eagle-Haliaeetus leucocephalus 
Mississippi Kite-Ictinia mississippiensis 
Osprey-Pandion haliaetus 
Harris' Hawkc-Parabuteo unicinctus 
Family Falconidae 
Merlin-Falco columbarius 
Prairie Falcon-Falco mexicanus 
American Kestrel-Falco sparverius 
Order Galliformes 
Family Numididae  
Crested Guineafowlac-Guttera pucherani 
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Family Odontophoridae 
Northern Bobwhite-Colinus virginianus 
Family Phasianidae 
Chukarac-Alectoris chukar 
Ruffed Grouse-Bonasa umbellus 
Domestic Chicken (Red Junglefowl)c-Gallus gallus 
Green Junglefowlac-Gallus varius 
Impeyan (Himalayan) Pheasant (Monal)c-Lophophorus impeyanus 
Bulwer's Wattled Pheasantac-Lophura bulweri 
Turkey (domestic and wild)-Meleagris gallopavo 
Ring-necked Pheasant-Phasianus colchicus 
Mount Peacock-Pheasantac-Polypectron inopinatum 
Crested Partridgeac-Rollulus roulroul 
Blyth's Tragopanc-Tragopan blythii 
Argus Pheasant (unspecified)ac-various 
Order Gaviformes 
Family Caprimulgidae 
Common Loon-Gavia immer 
Order Gruiformes 
Family Accipitridae 
Black-necked Craneac-Grus nigricollis 
Family Gruidae 
Demoiselle Craneac-Anthropoides virgo 
West African Crowned Cranea-Balearica pavonina pavonina 
Wattled Craneac-Bugeranus carunculatus 
Whooping Craneac-Grus americana 
Mississippi Sandhill Cranec-Grus canadensis pulla 
Red-crowned Craneac-Grus japonensis 
Siberian Craneac-Grus leucogeranus 
Hooded Craneac-Grus monacha 
White-naped Craneac-Grus vipio 
Family Rallidae 
Virginia Rail-Rallus limicola 
Order Musophagiformes 
Family Musophagidae 
Lady Ross' Turaco (Plantain-Eater)ac-Musophaga rossae 
Order Passeriformes 
Family Bombycillidae 
Cedar Waxwing-Bombycilla cedrorum 
Family Cardinalidae 
Northern Cardinal-Cardinalis cardinalis 
Blue Grossbeaka-Guiraca caerulea 
Dickcissel-Spiza americana 
Family Corvidae 
Western Scrub-Jay-Aphelocoma californica 
American Crow-Corvus brachyrhynchos 
Common Raven-Corvus corax 
Fish Crow-Corvus ossifragus 
Blue Jay-Cyanocitta cristata 
Steller's Jay-Cyanocitta stelleri 
Black-billed Magpiec-Pica hudsonia 
Family Emberizidae 
Song Sparrow-Melospiza melodia 
Savannah Sparrow-Passerculus sandwichensis 
Fox Sparrow-Passerella iliaca 
Eastern Towhee-Pipilo erythrophthalmus 
Field Sparrow-Spizella pusilla 
Family Estrildidae 
Zebra Finchc-Taeniophygia guttata 
Family Fringillidae 
American Goldfinch-Carduelis tristis 
House Finch-Carpodacus mexicanus 
Purple Finch-Carpodacus purpureus 
Evening Grosbeak-Coccothraustes vespertinus 
European Goldfinchc-Carduelis carduelis 
Family Hirundinidae 
Barn Swallow-Hirundo rustica 
Purple Martin-Progne subis 
Family Icteridae 
Red-Winged Blackbird-Agelaius phoeniceus 
Rusty Blackbird-Euphagus carolinus 
Brewer's Blackbird-Euphagus cyanocephalus 
Baltimore Oriole-Icterus galbula 
Brown-headed Cowbird-Molothrus ater 
Boat-tailed Grackle-Quiscalus major 
Great-tailed Grackle-Quiscalus mexicanus 
Common Grackle-Quiscalus quiscula 
Family Laniidae 
Loggerhead Shrike-Lanius ludovicianus 
Family Mimidae 
Gray Catbird-Dumetella carolinensis 
Northern Mockingbird-Mimus polyglottos 
Brown Thrasher-Toxostoma rufum 
Family Paridae 
Tufted Titmouse-Baeolophus bicolor 
Varied Titc-Parus varius 
Black-capped Chickadee-Poecile atricapilla 
Carolina Chickadee-Poecile carolinensis 
Family Parulidae 
Black-throated Blue Warbler-Dendroica caerulescens 
Yellow-rumped Warbler-Dendroica coronata 
Yellow Warbler-Dendroica petechia 
Blackpoll Warbler-Dendroica striata 
Common Yellowthroat-Geothlypis trichas 
Kentucky Warbler-Oporornis formosus 
Northern Parula-Parula americana 
Ovenbird-Seiurus aurocapillus 
Northern Waterthrush-Seiurus noveboracensis 
Nashville Warbler-Vermivora ruficapilla 
Canada Warbler-Wilsonia canadensis 
Hooded Warbler-Wilsonia citrina 
Family Passeridae 
House Sparrow-Passer domesticus 
Family Sylviidae 
White-crested Laughingthrushac-Garrulax leucolophus 
Family Sittadae 
White-breasted Nuthatch-Sitta carolinensis 
Family Sturnidae 
European Starling-Sturnus vulgaris 
Family Troglodytidae 
Carolina Wren-Thryothaurus ludovicianus 
Winter Wren-Troglodytes troglodytes 
Family Turdidae 
Veery-Catharus fuscescens 
Hermit Thrush-Catharus guttatus 
Gray-cheeked Thrush-Catharus minimus 
Swainson's Thrusha-Catharus ustulatus 
Wood Thrush-Hylocichla mustelina 
Eastern Bluebird-Sialia sialis 
American Robin-Turdus migratorius 
Family Tyrannidae 
Traill's Flycatcher-Empidonax traillii/alnorum 
Eastern Phoebe-Sayornis phoebe 
Scissor-tailed Flycatcher-Tyrannus forficatus 
Eastern Kingbird-Tyrannus tyrannus 
Family Vireonidae 
Black-whiskered Vireo-Vireo altiloquus 
Warbling Vireo-Vireo gilvus 
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Order Pelecaniformes 
Family Pelecanidae 
American White Pelican-Pelecanus erythrorhynchos 
Brown Pelicanac-Pelicanus occidentalis 
Family Phalacrocoracidae 
Double-crested Cormorant-Phalacrocorax auritus 
Guanay Cormorantc-Phalacrocorax bougainvillei 
Order Piciformes 
Family Picidae 
Red-headed Woodpecker-Melanerpes erythrocephalus 
Downy Woodpecker-Picoides pubescens 
Yellow-bellied Sapsucker-Sphyrapicus varius 
Order Podicipediformes 
Family Podicipedidae 
Pied-billed Grebe-Podilymbus podiceps 
Order Psittaciformes 
Family Cacatuidae 
Cockatoo (unspecified)c-Cacatua spp. 
Cockatielc-Nymphicus hollandicus 
Family Psittacidae 
Red-crowned Parrotc-Amazona viridigenalis 
Macaw (unspecified)c-Ara spp. 
Budgerigarc-Melopsittacus undulatus 
Lorikeet spp.c-Tricheglossus spp. 
Order Spheniscformes 
Family Spheniscidae 
Black-footed (Jackass) Penguinc-Spheniscus demersus 
Magellan Penguinac-Spheniscus humboldti 
Order Strigiformes 
Family Strigidae 
Northern Saw-whet Owl-Aegolius acadicus 
Short-eared Owl-Asio flammeus 
Verreaux's Eagle Owl (Milky Eagle Owl)ac-Bubo lacteus 
Great Horned Owl-Bubo virginianus 
Snowy Owlc-Nyctea scandiaca 
Eastern Screech Owl-Otus asio 
Tawny Owlc-Strix aluco 
Barred Owl-Strix varia 
Family Tytonidae 
Barn Owl-Tyto alba 
Order Struthioniformes 
Family Struthionidae 
Ostrichac-Struthio camelis 
 
Mammals 
Order Artiodactyla 
Family Bovidae 
Domestic Cattlec-Bos taurus 
Mountain Goatc-Oreamnos americanus 
Domestic (Suffolk) Sheepc-Ovis aries 
Family Camelidae 
Llamac-Lama glama 
Alpaca (Suri)c-Lama pacos 
Family Cervidae 
White-tailed Deera-Odocoileus virgninianus 
Reindeerc-Rangifer tarnadus 
Family Suidae 
Babirusaac-Babyrousa babyrousa 
Order Carnivora 
Family Canidae 
Domestic Dogc-Canis familiaris 
Timber Wolfc-Canis lupus 
Family Felidae 
Domestic Cat (feral)-Felis catus 
Family Mustelidae 
Striped Skunk-Mephitis mephitis 
Family Phocidae 
Harbor Sealc-Phoca vitulina 
Family Procyonidae 
Red Pandaac-Ailurus fulgens fulgens 
Family Ursidae 
Black Beara-Ursus americanus 
Order Chiroptera 
Family Vespertilionidae 
Big Brown Bat-Eptesicus fuscus 
Little Brown Bat-Myotis lucifugus 
Order Lagomorpha 
Family Leporidae 
Domestic Rabbitc-Oryctolagus cuniculus 
Order Perissodactyla 
Family Equidae 
Domestic Horsec-Equus equus przewalski caballus 
Donkeyc-Equus asinus 
Mulec- 
Family Rhinocerotidae 
Great Indian Rhinocerosac-Rhinoceros unicornis 
Order Primata 
Family Cercopithcidae 
Barbary Macaquec-Macaca sylvanus 
Family Lemuridae  
Ring-tailed Lemurac-Lemur catta 
Order Proboscidea 
Family Elephantidae 
Indian (Asian) Elephantac-Elephas maximus indicus 
Order Rodentia 
Family Sciuridae 
Gray Squirrel-Sciurus carolinensis 
Fox Squirrel-Sciurus niger 
Eastern Chipmunk-Tamias striatus 
Reptiles 
Order Crocodylia 
Family Alligatoridae 
American Alligatorc-Alligator mississippiensis 
Order Squamata 
Family Varanidae 
Crocodile Monitorac-Varanus salvadorii 
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APPENDIX B 
RESULTS OF HUMAN SURVEILLANCE FOR WNV IN MARICOPA COUNTY, 2002 
 
Maricopa County has experienced a slow but steady increase in the rate of viral 
meningitis/encephalitis cases reported in the past 4 years as shown in Chart 1. 
Of the 200 cases reported during the mosquito season 2002 21 are not considered in the data as 
they were ruled out (8), duplicate (4), or out of jurisdiction (9).  
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Chart 1 
 
Chart 2 represents the remaining 179 cases by the month report was received. Date of symptom 
onset (which would more clearly illustrate the seasonal peak of disease) was not used in this 
report due to the fact that onset data were missing in more than one third of the reports. The 
average lag time between symptom onset to date received in cases with available data was 14.2 
days (range 1-38 days).  
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Chart 2 
Of the 179 cases of viral CNS disease reported during the period of enhanced surveillance 50 met 
age criteria for WNV investigation. The Charts 3 -5 illustrate the general demographics of this 
group including age, sex race and location. 
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Viral Meningitis Cases Meeting Age Criteria by Age 
Group (2002)
MALE
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17%
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Viral Meningitis Cases Meeting Age Criteria by Age 
Group/Sex (2002)
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35-45 y/o 45-64 y/o 65+
 
Chart 3 
 
Viral Meningitis Cases Meeting Age Criteria by Race 
(2002)
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Chart 4 
 
 
 
Map 2 
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Results of Enhanced Human Surveillance 
In addition to the 50 cases meeting age criteria 7 more investigations were initiated for cases 
reported as aseptic meningitis exhibiting paresthesias (3), numbness (2) or altered mentation 
(2). 
 
In August, as the national case count grew beyond all expectations and media coverage of the 
WNV epidemic intensified many private physicians began requesting WNV testing of the ASHL. As 
a result county epidemiologists were required to triage all request for testing using the 
established criteria prior to the specimen delivery to the lab. As some requests were for non-
hospitalized patients with strictly upper respiratory symptoms, headache alone or history of travel 
to a WNV endemic area without symptoms, any request not meeting criteria was referred to a 
commercial laboratory for testing. More than 50 such consultations resulted in 21 samples to the 
ASHL, 15 to commercial labs.  
Table 2 shows the degree of symptomatology of the 57 cases investigated in Maricopa County for 
2002. These data reveal significant differences in symptom breakdown from cases of WNV 
disease in NYC (see Historical Data: NYC Experience).  
Symptom % With 
symptom 
Headache  54 
Gi 34 
Fever 32 
Photophobia 18 
Weakness 16 
Altered mentation 16 
Neck pain/stiffness 14 
Arthralgia/Myalgia 8 
Seizure 6 
Other 16 
 
Symptomatology of Viral Meningitis/Encephalitis Cases investigated 2002 
Table 3 
 
Of the 57 viral meningitis/encephalitis case investigations carried out this summer in Maricopa 
County 2 patients tested positive for WNV IgM. In the first case a woman with a travel/mosquito 
bite history in Ohio approximately 10 days prior to the onset of headache, fever, nausea, 
vomiting and stiff neck was admitted to a local hospital in August. The second patient gave 
history of having spent the summer in Indiana; 4 days after returning to her winter home in 
Arizona she began to experience headache, neck pain and extreme fatigue. The WNV serology, 
which was initially done at a commercial lab, was confirmed by the ASHL.  
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APPENDIX C 
COSTS OF ENHANCED SURVEILLANCE FOR WNV IN MARICOPA COUNTY, 2002 
 
At the start of the enhanced surveillance period no measures were taken to account for the 
expenses of the effort as its magnitude was unexpected and underestimated. Listed below are 
the cost per epidemiologist involved during the surveillance period by hourly pay rate factoring in 
indirect and personnel costs (indirect: $ 0.157, personnel: $1.161). 
 
ACTIVITY TOTAL COST ($) 
MC lab draws  
Epi person/hours:  
Planning  
Triage/ Consults  
Investigating  
Correspondence/Mailings  
Reports  
  
Aggregate  
Epidemiologist 662.02 
Epidemiologist 1560.01 
Epidemiologist 17,713.35 
Total 19,935.38 
T able 4 
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APPENDIX D 
 
MARICOPA COUNTY DEPARTMENT OF PUBLIC HEALTH 
EPIDEMIOLOGY/SURVEILLANCE PLAN FOR WEST NILE VIRUS 2003 
 
Prepared by Mare Schumacher 
Updated 12/17/02 
 
Background and Current Enhanced Surveillance Efforts 
 
In the U.S. as of December 11, 2002, there have been 3829 cases of human West Nile Virus 
(WNV) illness, resulting in 225 deaths.  WNV activity has been documented in 42 states including 
the Arizona border states of Colorado, California (human case) and New Mexico (veterinary 
samples).  In Arizona, 4 human (Pima-2, Maricopa-2) and 3 equine (Pima-1, Cochise-1, Maricopa-
1) WNV positive cases have been identified.  All of these cases had exposures outside of Arizona. 
Predictions are for Maricopa County to see it's first cases of endemic WNV during the 
spring/summer of 2003. 
 
Increased efforts to detect WNV illness in Maricopa County were instituted last summer. Human 
surveillance for WNV in Maricopa County was expanded during the mosquito season (May thru 
October).  In addition to routine testing for all encephalitis cases, samples for selected cases of 
aseptic meningitis were submitted to the State laboratory by MCDPH and other county health 
departments.  This practice will continue into 2003. 
 
Last year, surveillance of animals susceptible to WNV was also enhanced.  The MCDPH, the 
Arizona Department of Health Services’ Vector-borne and Zoonotic Disease Program, the Arizona 
Veterinary Diagnostic Laboratory, and Maricopa County Vector Control collaborated to enhance 
dead bird, sentinel chicken flock, mosquito pool and equine testing for WNV.   
 
Enhanced Surveillance Efforts for 2003 
 
Because WNV illness is transmitted by mosquitoes, enhanced surveillance will need to begin 
again in April of 2003 and surveillance can be expected to continue into December 2003.  During 
this period, the MCDPH surveillance team (epidemiology staff and community health nursing 
surveillance staff) will need to conduct investigations of all suspect WNV cases.  Due to the media 
interest in WNV, the team expects a greater number of suspect cases in 2003, in addition to the 
expected actual cases. Surveillance and investigations will include the following activities: 
 
Arbovirus testing for: 
· All viral encephalitis cases (routine) 
· Selected viral meningitis cases:  
§ >35 y/o 
§ altered mentation 
§ seizure 
§ profound muscle weakness 
§ flaccid paralysis 
§ spastic paralysis  
Testing will be performed at the AZ State Health Laboratory at the request of MCDPH. 
 
Telephone triage: 
  
· Contact hospitalized cases (ICP’s providers)  
 23 
· Interview outpatient cases and get information on specimens (providers, labs) 
· Communicate with community members with questions 
 
Site visits: 
  
· Review medical records for hospitalized cases  
· Interview hospitalized/convalescing patients  
· Collect convalescent specimens and/or lab results  
 
Data management: 
 
· Collect case information 
· Complete data entry 
· Analyze data 
· Clean and maintain database 
· Produce reports 
 
Community outreach: 
  
· Distribute initial fact sheet to providers/Infection Control Practitioners (see Attachment A) 
· Provide pamphlets 
· Provide regular updates to reinforce protocols and disseminate new info (see Attachment 
B) 
· In addition to MCDPH efforts, public service announcements are currently being 
negotiated by ADHS with Cox Communication   
 
 
 
Resources Needed for Epidemiology for Summer 2003 West Nile Virus Enhanced Surveillance 
and Outbreak Response 
 
When the disease arrives in Arizona, the surveillance team will need to investigate every suspect 
case of WNV and field questions and concerns from the public.  With even as few as one suspect 
case per day, the surveillance investigation workload will increase significantly as each case 
requires a full interview of the patient, communication with labs, hospitals and the patient’s 
medical provider, in addition to follow-up interviews, site visits and blood draws.   
 
In order to meet the demand that the introduction of WNV into Arizona will produce, the 
Epidemiology and Community Health Nursing staff request $99,057.37 in additional funds.   
 
Requested funds would cover 1 surveillance nurse and 1 administrative assistant to help the 
existing staff handle the increased number and types of activities needed.  All positions would be 
hired on a full-time basis for 35 weeks of the year (to cover the mosquito season).  The 
administrative Assistant would be hired from a temporary service at the rate of $14.30 per hour.  
Hiring a partial-year surveillance nurse may be more difficult.  The MCDPH typically hires 
temporary nursing help from a nurse pool at $30-35 per hour.  However, the WNV surveillance 
nurse will need to have analytical and research skills in addition to basic nursing skills.  The 
estimated cost per hour for a temporary surveillance nurse is $52.00 per hour (including an 
additional $6/hour for research skills).  Job descriptions for each of the positions are provided 
below. 
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Surveillance Nurse 
 
The WNV surveillance nurse would be responsible for all parts of a WNV investigation, including: 
· Completing diagnostic telephone interviews of all suspect cases to determine if probable 
cases 
· Conducting medical and personal interviews of probable cases 
· Securing blood samples (through a blood draw) for probable cases 
· Telephone triage with medical providers and hospitals to get lab results 
· Following up with suspect and probable cases for changes in conditions, new lab tests, 
etc. 
MCDPH expects to pay more for a qualified surveillance nurse than for a pool nurse.  A qualified 
surveillance nurse has not only medical knowledge, but research skills as well. 
  
Administrative Assistant/Data Entry Clerk 
 
Administrative assistants will provide administrative support to the surveillance nurse and the 
epidemiologists.  This will include: 
 
· Data entry of completed lab results, questionnaires, and other forms 
· Setting up appointments and communication with patients 
· Typing, copying communication items for hospitals 
· Picking-up or delivering of interviews, lab results or other items from hospitals, patients’ 
homes, or labs  
 
Total Costs 
 
As shown in the table below, the total cost for one administrative assistant, one surveillance 
nurse, computer/software, travel, and pamphlets is $99,057.37. 
 
Table 1.  Cost for Enhanced WNV Surveillance 
 Cost per hour/unit Number of 
hours/units  
Total Cost 
Surveillance nurse $52.00 1400 $72,800.00 
Administrative assistant $14.30 1400 $20,020.00 
Computer $2,197.00 2 $4,394.00 
Software (Access) $400.00 2 $800.00 
Travel  .345 per mile 1575 miles $543.37 
Pamphlets .50 per pamphlet 1000 pamphlets $500.00 
Total Request   $99,057.37 
Note: Computers will be needed for administrative assistants to enter data.  The surveillance 
nurse will use the division’s laptop, when needed. 
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Maricopa County Department of Public Health 
Division of Epidemiology/BDPR 
Contact Numbers (all 602 area code) 
 
 
Vjollca Berisha Senior Epidemiologist 506-6802 
Garrett Booth Epidemiologist 506-1027 
John Carlson Senior Epidemiologist 506-6829 
Alisa Diggs-Gooding Epidemiologist 506-6811 
Andrew Edmonds Data Analyst 506-3252 
Joesette Frausto Administrative Assistant 506-6439 
Jeanette Gibbon  Epidemiologist 506-6801 
Ron Klein Disease Surveillance Sup 506-6722 
Ashraf Lasee Epidemiologist 506-3062 
Chris Mahon Program Admin, CHN 506-6771 
Yanita Moore Data Entry Clerk 506-6805 
Liva Nohre Senior Epidemiologist 506-6826 
Lawrence Sands Director, BDPR 506-6821 
Sarah Santana Director, Epidemiology 506-6952 
Mare Schumacher Deputy Director, Epi 506-3078 
Heather Wanatowicz Administrative Supervisor 506-6825 
Gary West Statistical Programmer 506-6830 
 
 
To report communicable diseases, unusual health occurrences, and public health 
emergencies (all 602 area codes unless otherwise noted) 
 
 Business hours   After hours 
 M-F 7-5 
Bite reports 506-7387                 506-2752 
Communicable diseases       506-6868 or 506-6767      480-303-1100 
Death certificates,  506-6805                450-9982 or  
 funeral homes,                  420-2839 
 human remains     
HIV (reports)       506-6426 or 506-6871           Not available 
Public health emergencies 339-8749              480-303-1100 
Rabies 506-7387                     506-3334 
STDs (other than HIV)       506-6364 or 506-6147           Not available 
TB 372-6661              480-303-1100 
 
   
 
 
 
 
